ROUNDUP: Teva Pharma Boosts FY23 Revenue Outlook
PETAH TIKVA (dpa-AFX) - While reporting financial results for the second quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed…
20,450€
3,54%
Echtzeit-Aktienkurs Teva Pharmaceutical Industries Ltd. ADR
Bid:
Ask:
Nachrichten zur Teva Pharmaceutical Industries Ltd. ADR Aktie
Teva Pharmaceutical Industries Limited Q2 Earnings Summary
PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$863 million in Q2 vs.…
Teva Pharmaceutical hoping for Q2 recovery after Q1 EPS disappointment.
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Exelixis, Teva settle patent dispute over cancer drug Cabometyx
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceuticals and Alvotech expand biosimilars partnership
Teva Pharmaceuticals Industries Ltd. TEVA and Alvotech ALVO announced Monday that they are expanding their collaboration in the U.S. biosimilars…
Teva, Alvotech Announce Expanded Strategic Partnership For Biosimilars
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced on Monday that it has agreed with Alvotech (ALVO) to…
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic…
Meilenstein für die Medizin von Morgen: Teva investiert in hochmoderne Biotech-Anlage
Drees & Sommer SE: Ulm (ots) - Es ist ein Projekt der Superlative: Die Ratiopharm-Mutter Teva investiert am Standort Ulm…
TEVA Pharmaceutical: Upgrade
Zürich (www.aktiencheck.de) - Rating-Update:
Ashwani Verma, Analyst der UBS, stuft die Aktie des Biotechkonzerns TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098,…
Teva mulls $2b sale of API activities - report
The Israeli pharmaceutical company is working with advisors to gauge interest on such a sale, "Bloomberg" reports....…
Teva considering $2B sale of active pharmaceutical ingredients unit -report
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva (TEVA) Explores Sale of $2 Billion Active Ingredients Unit
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva seeks to reinvent itself as branded drug developer
After years of shrinking revenue, new CEO Richard Francis is switching the emphasis to innovation. "Globes" looks at Tevas drug…
Gilead, Teva acquitted in pay for delay generic HIV drugs case
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Deckers (DECK) to Benefit From Brand Strength Amid Headwinds
Deckers Outdoor (DECK) is well poised to benefit from strength across its HOKA and Teva brands, store expansion initiatives and…
Form 8-K TEVA PHARMACEUTICAL INDU For: Jun 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva settles price-fixing claims with State of Kentucky for $1.41M (update)
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceuticals Reaches Deal With Kentucky AG To Settle Price-fixing Claims
PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, the U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (TEVA), Monday said it has reached…
Teva settles price-fixing claims with State of Kentucky for $1.41B
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO),…
Why did Teva fall 20% in April-May?
An SEC filing reveals that major US-based shareholder Capital Research Global Investors sold its entire holding....…
Teva Pharmaceutical settles $193M opioid suit with the state of ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It
Teva, Allergan, CVS and Walgreens said enough states agreed to final agreements, adding to the billions flowing to communities....…
Teva, Walgreens, CVS, AbbVie to pay $17.3B in national opioid settlement
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NY AG approves $17.3 billion opioid settlement with CVS, Walgreens, Teva and AbbVie’s Allergan
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
BRIEF-Attorney General James Announces Final National Settlement Agreements For $17.3 Bln With Teva, CVS And Walgreens - Statement
...June 9 (Reuters) -
* ATTORNEY GENERAL JAMES ANNOUNCES FINAL NATIONAL......…
Hot Stocks: CVNA rises on upbeat Q2 outlook; GME dips on firing CEO; AMZN, TEVA gain; SIG, GME fall
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Settles Nationwide Opioids Agreement
PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd (TEVA), announced on Thursday that it…
Teva completes US nationwide settlement on opioids
Teva will pay Nevada $193 million over 20 years, making it the final state to conclude an agreement with the…
Teva Pharmaceutical settles opioid litigation with all 50 states
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K TEVA PHARMACEUTICAL INDU For: Jun 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva to pay Nevada $193 million over role in opioid epidemic
...By Brendan Pierson
(Reuters) - Teva Pharmaceutical Industries......…
Phil, Teva Partner To Help Patients To Receive, Refill Digihaler Medication
PETAH TIKVA (dpa-AFX) - Phil Inc. announced an agreement with Teva Pharmaceuticals that will make Digihaler products available for prescription…
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
Its unclear whether the pivot will be enough to halt its recent decline....…
Teva Pharmaceutical S&P rating outlook changed to stable from positive
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Deckers (DECK) Q4 Earnings Beat Estimates, HOKA Brand Aids
Deckers Outdoors (DECK) fourth-quarter fiscal 2023 results reflect a 7.5% increase in net sales, driven by the strength of its…
Teva is Said to Explore Options for Bowel Inflammation Drug
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
TEVA Pharmaceutical: Ersteinschätzung
New York (www.aktiencheck.de) - Rating-Update:
Thibault Boutherin, Analyst von Morgan Stanley, startet die Coverage der Aktie von TEVA Pharmaceutical Industries Ltd.…
Der Branchenriese Teva verliert Interesse an Generika – Medikamente dürften noch knapper werden
Medikamentenkopien können nicht billig genug sein. Der neue Chef des weltweit zweitgrössten Generikaherstellers, Teva Pharmaceuticals, zieht aus dem Preiskampf seine…
3 Generic Drug Stocks to Watch Amid Macro Headwinds
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite…
Sun: Teva drags TASE down
Teva led the declines today as Tower and Nova bucked the market....…
Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80%
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Watch Teva to Make Fewer Generic Drugs
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Plans to Cut Back Generic Drug Production Even As Shortages ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Will Slim Down Its Generic Drug Business
The new corporate strategy aims to deliver a “pivot to growth," the drugmaker said....…
Why Teva Pharmaceutical Stock Is Jumping Today
Investors are reacting positively to Tevas new growth strategy....…
Teva targets growth through innovation
Tevas new strategy stresses growth through branded drugs and biosimilars. The company sees Austedo sales of $2.7 billion in 2027....…
Teva gains after announcing new growth strategy; Evercore upgrades
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceutical announces new growth strategy built on biosimilars, innovation
Teva Pharmaceutical Industries on Thursday launched a new “pivot to growth” strategy, based on existing growth drivers like Austedo and…
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute
...By Blake Brittain
WASHINGTON (Reuters) -The U.S. Supreme Court......…